iCAD, Inc.
iCAD, Inc. (ICAD) Financial Performance & Income Statement Overview
Review iCAD, Inc. (ICAD) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
iCAD, Inc. (ICAD) Income Statement & Financial Overview
Review iCAD, Inc. ICAD income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $4.87M | $5.41M | $4.22M | $5.03M |
| Cost of Revenue | $685000.00 | $738000.00 | $583000.00 | $812000.00 |
| Gross Profit | $4.19M | $4.67M | $3.63M | $4.22M |
| Gross Profit Ratio | $0.86 | $0.86 | $0.86 | $0.84 |
| R&D Expenses | $1.48M | $1.41M | $1.93M | $1.76M |
| SG&A Expenses | $3.79M | $4.06M | $3.67M | $4.34M |
| Operating Expenses | $5.26M | $5.54M | $5.65M | $6.10M |
| Total Costs & Expenses | $5.95M | $6.15M | $6.23M | $6.98M |
| Interest Income | $172000.00 | $192000.00 | $210000.00 | $206000.00 |
| Interest Expense | $0.00 | $12000.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $114000.00 | $174000.00 | $113000.00 | $177000.00 |
| EBITDA | -$1.01M | -$589000.00 | -$1.68M | -$1.55M |
| EBITDA Ratio | -$0.21 | -$0.11 | -$0.40 | -$0.31 |
| Operating Income | -$1.13M | -$865000.00 | -$2.02M | -$1.95M |
| Operating Income Ratio | -$0.23 | -$0.16 | -$0.48 | -$0.39 |
| Other Income/Expenses (Net) | $296000.00 | $90000.00 | $220000.00 | $217000.00 |
| Income Before Tax | -$833000.00 | -$775000.00 | -$1.79M | -$1.73M |
| Income Before Tax Ratio | -$0.17 | -$0.14 | -$0.43 | -$0.34 |
| Income Tax Expense | $0.00 | $79000.00 | $6000.00 | $8000.00 |
| Net Income | -$833000.00 | -$854000.00 | -$1.80M | -$1.74M |
| Net Income Ratio | -$0.17 | -$0.16 | -$0.43 | -$0.35 |
| EPS | -$0.03 | -$0.03 | -$0.07 | -$0.07 |
| Diluted EPS | -$0.03 | -$0.03 | -$0.07 | -$0.07 |
| Weighted Avg Shares Outstanding | $26.71M | $26.35M | $26.35M | $26.35M |
| Weighted Avg Shares Outstanding (Diluted) | $26.71M | $26.35M | $26.35M | $26.35M |
Over the past four quarters, iCAD, Inc. demonstrated steady revenue growth, increasing from $5.03M in Q2 2024 to $4.87M in Q1 2025. Operating income reached -$1.13M in Q1 2025, maintaining a consistent -23% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$1.01M, reflecting operational efficiency. Net income rose to -$833000.00, with EPS at -$0.03. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan